Detecting EGFR Mutations in Patients with Non-small Cell Lung Cancer

Mutations in the receptor of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC) are used as biomarkers for predicting the response of treatment with EGFR tyrosine kinase inhibitors (EGFR TKIs). Non-small cell lung cancer patients usually have activating EGFR mutations...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Balkan J Med Genet
Autors principals: Hammoudeh, ZA, Antonova, O, Staneva, R, Nikolova, D, Kyuchukov, Y, Penev, A, Mintchev, T, Koleva, V, Hadjidekova, S, Toncheva, D
Format: Artigo
Idioma:Inglês
Publicat: Sciendo 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6231315/
https://ncbi.nlm.nih.gov/pubmed/30425905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/bjmg-2018-0013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars